Literature DB >> 19453351

Key opinion leaders: where they come from and how that affects the drugs you prescribe.

Jeffrey J Meffert1.   

Abstract

Key opinion leaders (KOLs), also known as thought leaders, are the experts in their field upon whom we depend for original research leading to disease understanding and new therapies. We rely on them to write the articles, author the textbooks, and give the presentations that we absorb to become better dermatologists. KOLs have become intimately entwined with the marketing of pharmaceuticals and medical devices, used not only to lend credibility to claims of efficacy and safety but also to promote anecdotal and off-label use of these medications to increase industry profits. Identification and marketing of the KOLs themselves is being done more and more often by KOL management companies who are hired by industry to turn those involved in medical education and research into efficient and productive members of the sales force.

Mesh:

Substances:

Year:  2009        PMID: 19453351     DOI: 10.1111/j.1529-8019.2009.01240.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  8 in total

1.  How to make opinion leaders and influence people.

Authors:  Sergio Sismondo
Journal:  CMAJ       Date:  2015-07-06       Impact factor: 8.262

2.  Types and Distribution of Payments From Industry to Physicians in 2015.

Authors:  Kathryn R Tringale; Deborah Marshall; Tim K Mackey; Michael Connor; James D Murphy; Jona A Hattangadi-Gluth
Journal:  JAMA       Date:  2017-05-02       Impact factor: 56.272

3.  Knowledge of ghostwriting and financial conflicts-of-interest reduces the perceived credibility of biomedical research.

Authors:  Jeffrey R Lacasse; Jonathan Leo
Journal:  BMC Res Notes       Date:  2011-01-31

4.  Disparities in industry funding among Colorectal Surgeons: a cross-sectional study.

Authors:  Alessandra Storino; Carolina Vigna; John C Polanco-Santana; Ernest Park; Kristen Crowell; Anne Fabrizio; Thomas E Cataldo; Evangelos Messaris
Journal:  Surg Endosc       Date:  2022-02-01       Impact factor: 3.453

5.  Medication Use Among Patients With COVID-19 in a Large, National Dataset: Cerner Real-World Data™.

Authors:  Stephanie J Stroever; Daniel Ostapenko; Robyn Scatena; Daniel Pusztai; Lauren Coritt; Akua A Frimpong; Paul Nee
Journal:  Clin Ther       Date:  2021-04-15       Impact factor: 3.393

6.  The speakers' bureau system: a form of peer selling.

Authors:  Lynette Reid; Matthew Herder
Journal:  Open Med       Date:  2013-04-02

7.  Association between physician characteristics and payments from industry in 2015-2017: observational study.

Authors:  Kosuke Inoue; Daniel M Blumenthal; David Elashoff; Yusuke Tsugawa
Journal:  BMJ Open       Date:  2019-09-20       Impact factor: 2.692

8.  Sunshine on KOLs: assessment of the nature, extent and evolution of financial ties between the leaders of professional medical associations and the pharmaceutical industry in France from 2014 to 2019: a retrospective study.

Authors:  Marie Clinckemaillie; Alexandre Scanff; Florian Naudet; Adriaan Barbaroux
Journal:  BMJ Open       Date:  2022-02-02       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.